A U.S. Judge Is Enabling Tech's Campaign To Crush Startup Competitors


By Paul Michel


Startups across the nation are on edge -- and for good reason.

A District Court judge in Delaware recently imposed rigid and burdensome disclosure requirements including on companies that sue their much larger rivals for patent infringement.

If the judge's Standing Orders survive, it will give Big Tech defendants in infringement cases a huge tactical advantage. Defendants can use fights over compliance with the disclosure requirements to slow cases down, delay judgments and increase plaintiffs' legal costs.

In short, the new requirements will make it even easier for Big Tech firms to employ a strategy of "efficient infringement" -- willfully stealing smaller rivals' technology and then mustering armies of lawyers to drag out any lawsuits until the cash-strapped startups cry uncle and settle out-of-court for pennies on the dollar.

This typical disparity in resources is why startups and smaller innovators often seek third-party funding for infringement cases.

But why would an investor help pay for someone else's patent-infringement lawsuit?

Well, certain investment funds, having watched this growing trend in "efficient infringement," spotted an opportunity to help these startups -- and themselves. In effect, they agree to cover the costs of a lawsuit in return for a share of any damages.

Unsurprisingly, Big Tech is unhappy about all this. So it has launched a campaign against third-party litigation funding.

The right to sue for damages incurred is an essential feature of the American judicial system -- and third-party funding in various forms has long been a part of it.

Lawyers take cases on contingency, effectively funding clients' cases with returns dependent on a win. Parties in all kinds of cases -- from worker compensation to tenant-landlord disputes to civil rights -- rely on donations, loans, and pro-bono legal work. Third-party financing is not some unique feature of patent litigation.

Federal rules already require litigants to disclose major ownership stakes.

But Judge Colm Connolly's added requirements go much further, demanding disclosure of all funders along with "every owner, member, and partner of the [litigating] party, proceeding up the chain of ownership until the name of every individual and corporation with a direct or indirect interest in the party has been identified."

The judge departed from the prevailing view in most courts throughout the United States that the funders of a lawsuit are irrelevant to the merits of the lawsuit itself.

Connolly's orders have sparked much controversy and two petitions before the U.S. Court of Appeals for the Federal Circuit seeking emergency relief from this judicial imposition (albeit denied as being premature).

Big Tech companies say they just want "transparency" and "disclosure." The ongoing "disclosure" campaign could tie up small patent holders in expensive legal knots over issues irrelevant to the merits and only rarely relevant to case management.

If the Goliaths continue to get their way, it could curtail American innovation and the job creation it brings for decades to come because startups are unusually innovative.

Paul Michel served on the United States Court of Appeals for the Federal Circuit from 1988 to his retirement in 2010, and as its chief judge from 2004 to 2010. This piece originally ran in RealClearPolicy.



More Resources


05/05/2024
Biden Has a Problem With Centrist Voters
Biden won the 2020 Democratic nomination as a self-described centrist, but has since adopted more liberal policies that could cost him in 2024.

more info


05/05/2024
Close Presidential Race Careens Toward Uncertain End


more info


05/05/2024
It's the Democrats' Turn To Scare America
No one should be surprised it ended up here.

more info


05/05/2024
Is Trump on Track To Blow the Election?


more info


05/05/2024
The Trump Trial, Columbia Anarchy--and Hope for New York


more info


05/05/2024
New Polls Show Kennedy a Growing Threat to Both Parties
By Adam Garrie, The Kennedy Beacon

more info


05/05/2024
'Equity' Grading Is Latest Educational Fad Destined To Fail
Why work extra hard when you won't be able to get an A? Why try to improve when you won't get worse than a C?

more info


05/05/2024
How Student Encampments Can Strengthen U.S.
Instead of defending the right to protest, many centrists are delegitimizing students, despite the value of what they're doing

more info


05/05/2024
Protesters Should Learn What Genocide Is
Universities are obliged to allow free speech. They are also obliged to make sure that students can attend classes free of harassment.

more info


05/05/2024
From Idealism to Irresponsibility


more info


05/05/2024
Venture Capital's Space for Sheep
vcs should invest in companies that create hype cycles, rather than those that simply follow them

more info


05/05/2024
Trump's Terrible, Horrible, No Good, Very Bad 2nd Term
Millions of us are justifiably focused on seeing that Donald Trump is held to account for what he's allegedly done in the past.

more info


05/05/2024
Biden Can't Win in a Fair Election Against Trump
Former President Donald Trump is getting dragged through the courts via the "lawfare" charges manufactured against him - and seemingly millions of liberals and Democrats are ecstatic. Chaos, turmoil and pain such as this can feel exhilarating when it's the other side's ox being gored.

more info


05/05/2024
Kennedy Jr.'s Plan To Make Biden Drop Out
Independent presidential candidate Robert F. Kennedy Jr. says President Joe Biden is the real "spoiler" in the 2024 presidential race, and he has a plan to make Biden drop out.

more info


05/05/2024
The Adults Are Still in Charge at the University of Florida
Higher education isn't daycare. Here are the rules we follow on free speech and public protests.

more info



Custom Search

More Politics Articles:

Related Articles

Pelosi's Drug Plan Would Kill Innovation -- and Hope


"Help is on the way." That's what House Speaker Nancy Pelosi told American patients when she unveiled her sweeping plan to lower drug prices.

Solving the Looming Superbug Crisis Will Require Bold Action From Congress


Antimicrobial resistance killed upwards of 160,000 Americans in 2010. More and more infections are becoming resistant to antibiotics and antifungals — and while Americans know this is a growing problem, few know how bad it already is.

One Nation Under God?


"I had no idea how critical religion is to the functioning of democracy." So said a Marxist economist from China conversing with Harvard Professor, Clayton Christensen.

The Art of the Budget Deal: White House and Congress Cooperate?


Last week, President Donald Trump and House Speaker Nancy Pelosi announced a two-year budget deal that suspends the debt ceiling, and will raise federal spending $320 billion over amounts agreed to during the Obama years.

Showdown with the Ayatollahs: A Dangerous Situation


Yesterday, President Donald Trump imposed more economic sanctions on Iran. In response, Iranian officials denounced the sanctions. Does diplomacy have a chance in this situation? Or is war inevitable?

AOC's Ravings Against Billionaires


"No one ever makes a billion dollars. You take a billion dollars."

House Drug Bill Dooms Medical Research


House lawmakers recently voted to pass the "Lower Drug Costs Now Act," which would enable government officials to set the price of lifesaving medicines. The bill would reduce pharmaceutical companies' revenues by a staggering $1 trillion over the coming decade.

To Boost the Economy, Fight Chronic Disease


To understand the health of an economy, look at the health of those who participate in it.

Animal Rights Groups Choose Coronavirus Over Your Safety


Top U.S. health officials recently delivered a sobering message: Americans must prepare for the inevitable spread of the coronavirus within the United States. So far in the U.S., 11 people have died. The virus has claimed the lives of more than 3,200 people and infected over 95,000 worldwide.

How To Draw On The Power Of Perseverance During COVID-19


People's ability to keep up their spirits is being put to the test during the COVID-19 pandemic. Health concerns, job concerns, and disruptions to day-to-day routines have combined to create a challenging situation for Americans and for people throughout the world.

Trump's "Buy America" Plan Will Backfire


In response to the ongoing coronavirus pandemic, the Trump administration wants to quarantine American manufacturing. At any time now, the president could sign an executive order aimed at returning the pharmaceutical supply chain to the United States.

Exercising Bayh-Dole March-in Rights Would Handicap COVID-19 Innovation


Scientists across America are working hard to develop treatments for and vaccines against COVID-19. Unfortunately, several activist groups are making their jobs harder.

Academic Research Can't End the Pandemic Without Private Backing


Scientists at Yale University and scores more research institutions nationwide are working around the clock to identify potential avenues of diagnosing, preventing, and treating COVID-19. Many of these projects are backed by the federal government's National Institutes of Health. Any one of them could lead to a game-changing insight that helps end this pandemic.

Natural Gas Will Power Our Economic Recovery


After months of sheltering in place, Americans are finally returning to their favorite restaurants, stores, and barbershops.

"All the News That's Fit to Print," As Long As It Promotes a Progressive Agenda


One hundred and 23 years later, the New York Times still boasts of its alleged objectivity with the phrase "All the News That's Fit to Print" located on the upper left-hand corner of its front page. The slogan was the idea of the paper's owner Adolph S. Ochs in 1897. He meant it as "a declaration of the newspaper's intention to report the news impartially," according to the language arts Website ReadWriteThink.